Professional Documents
Culture Documents
The McGrawHill
C o m p an ies , 2 0 0 2
CHAPTER
42
Industrial Microbiology
and B iote ch nology
Biodegradation often can
b e facilitated b y ch anging
env ironm ental conditions .
P oly ch lorinated b ip h eny ls
(P C Bs ) are w ides p read
indu s trial contam inants
th at accu m u late in
anaerob ic riv er m u ds .
A lth ou gh redu ctiv e
dech lorination occu rs
u nder th es e anaerob ic
conditions , ox y gen is
req u ired to com p lete th e
degradation p roces s . In
th is ex p erim ent, m u ds are
b eing aerated to allow th e
final b iodegradation s tep s
to occu r.
O utline
4 2 .1
4 2 .4
F inding M icroorganis m s in
N atu re 9 9 2
G enetic M anip u lation of
M icroorganis m s 9 9 3
P res erv ation of
M icroorganis m s 9 9 9
4 2 .2
4 2 .3
Biodegradation U s ing
N atu ral M icrob ial
C om m u nities 1 0 1 0
C h anging E nv ironm ental
C onditions to S tim u late
Biodegradation 1 0 1 2
A ddition of M icroorganis m s
to C om p lex M icrob ial
C om m u nities 1 0 1 5
M icroorganis m G row th
in C ontrolled
E nv ironm ents 1 0 0 0
M ediu m D ev elop m ent 1 0 0 0
G row th of M icroorganis m s in
an Indu s trial S etting 1 0 0 1
ntib iotics 1 0 0 4
m ino A cids 1 0 0 5
rganic A cids 1 0 0 6
p ecialty C om p ou nds for
U s e in M edicine and
H ealth 1 0 0 7
Biop oly m ers 1 0 0 7
Bios u rfactants 1 0 0 9
Bioconv ers ion
P roces s es 1 0 0 9
4 2 .5
Biotech nological
A p p lications 1 0 1 7
Bios ens ors 1 0 1 7
M icroarray s 1 0 1 8
Biop es ticides 1 0 1 8
992
X I. F ood a n d In d u stria l
M icrob iolog y
C oncep ts
1. Microorganisms are used in industrial microbiology and biotechnology to
create a wide variety of products and to assist in maintaining and improving
the environment.
2. Most work in industrial microbiology has been carried out using
microorganisms isolated from nature or modified through mutations. In
modern biotechnology, microorganisms with specific genetic characteristics
can be constructed to meet desired objectives.
3. Most microorganisms have not been grown or described. A major challenge
in biotechnology is to be able to grow and characteriz e these observed but
uncultured microorganisms in what is called bioprospecting.
4. Forced evolution and adaptive mutations now are part of modern
biotechnology. T hese can be carried out in processes termed natural
genetic engineering.
5. T he development of growth media and specific conditions for the
growth of microorganisms is a large part of industrial microbiology and
biotechnology. Microorganisms can be grown in controlled
environments with specific limitations to maximiz e the synthesis of
desired products.
6. Microbial growth in soils, waters, and other environments, where complex
microbial communities already are present, cannot be completely
controlled, and it is not possible to precisely define limiting factors or
physical conditions.
7. Microbial growth in controlled environments is expensive; it is used to
synthesiz e high-value microbial metabolites and other products for use in
animal and human health. In comparison, microbial growth in natural
environments usually does not involve the creation of specific microbial
products; microorganisms are used to carry out lower-value environmental
and agriculture-related processes.
8. In controlled growth systems, different products are synthesiz ed during
growth and after growth is completed. Most antibiotics are produced after
the completion of active growth.
9. Antibiotics and other microbial products continue to contribute to animal
and human welfare. Newer products include anticancer drugs.
Combinatorial biology is mak ing it possible to produce hybrid antibiotics
with unique properties.
10. T he products of industrial microbiology impact all aspects of our lives.
T hese often are bulk chemicals that are used as food supplements and
acidifying agents. Other products are used as biosurfactants and emulsifiers
in a wide variety of applications.
11. Degradation is critical for understanding microbial contributions to natural
environments. T he chemical structure of substrates and microbial
community characteristics play important roles in determining the fate of
chemicals. Anaerobic degradation processes are important for the initial
modification of many compounds, especially those with chlorine and other
halogenated functions. Degradation can produce simpler or modified
compounds that may not be less toxic than the original compound.
12. Biosensors are undergoing rapid development, which is limited only by the
advances that are occurring in molecular biology and other areas of science.
It is now possible, especially with streptavidin-biotin-link ed systems, to
have essentially real-time detection of important pathogens.
13. Gene arrays, based on recombinant DNA technology, allow gene
expression to be monitored. T hese systems are being used in the analysis of
complex microbial systems.
14. Bacteria, fungi, and viruses are increasingly employed as biopesticides,
thus reducing dependence on chemical pesticides.
15. Application of microorganisms and their technology has both positive and
negative aspects. Possible broader impacts of applications of industrial
microbiology and biotechnology should be considered in the application of
this rapidly expanding area.
42.1
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
993
Box 4 2.1
E stimated
T otal S p ecies
K now n
S p eciesa
P ercent
K now n
130,000b
?d
40,000b
1,500,000
60,000
5,000
500
4,800
69,000
40,000
[4] c
?
[12]
5
67
Small subunit (SSU) rR NA data indicate much higher in situ diversity than given by culture-based studies.
Source: D. A. Cowan. 2000. Microbial genomes the untapped resource. T ib tech 18:14 16. Table 2,
p. 15.
Adapted from: D. A. Cowan. 2000. Microbial genomes the untapped resource. T ib tech 18:14 16.
Table 1, p. 15.
that can be observed in nature have not been cultured or identified, although molecular techniques are making it possible to
obtain information on these uncultured microorganisms (table
42.2). W ith increased interest in microbial diversity and microbial ecology, and especially in microorganisms from extreme
environments (Box 42.1), microbiologists are rapidly expanding the pool of known microorganisms with characteristics desirable for use in industrial microbiology and biotechnology.
They are also identifying microorganisms involved in mutualistic and protocooperative relationships with other microorganisms and with higher plants and animals. There is continuing interest in bioprospecting in all areas of the world, and major
companies have been organized to continue to explore microbial diversity and identify microorganisms with new capabilities. Uncultured microorganisms and microbial diversity (section 6.5)
PrescottHarleyKlein:
Microbiology, Fifth Edition
994
The McGrawHill
Companies, 2002
Protoplast Fusion
4 7 - 6 36
4 7 - 6 50
4 7 - 6 38 [98 0]
4 7 -7 6 2
4 7 - 1327
4 7 - 138 0
4 7 - 156 4 [1,357 ]
4 7 - 911
4 7 - 104 0
UV
4 8 - 7 01 [1,36 5]
4 8 -7 4 9
N
4 8 -7 8 6
UV
4 8 - 137 2 [1,34 3]
UV
4 9- 4 8 2
4 9- 901
UV
4 9- 26 95
4 9- 24 29
UV
50- 529
50- 7 24
UV
50- 158 3
50- 124 7 [1,506 ]
UV
51- 8 25
UV
52- 8 5
UV
52- 8 17
UV
53- 17 4
UV
53- 8 4 4 [1,8 4 6 ]
4 8 - 16 55
4 9- 133 [2,230]
N
4 9- 2105
[2,26 6 ]
4 9- 216 6
N
50- 25
N
50- 935
N
51- 7 0
51- 20 [2,521]
52- 318
52- 108 7
53- 399
[2,6 58 ]
53- 4 14
[2,58 0]
51- 20A
51- 20B
51- 20F
51- 20A
51- 20B
F3 [2,14 0]
F 3- 6 4
[2,4 93]
strain NRRL 1951which was further improved through mutation (figure 42.1). Today most penicillin is produced with
Penicillium chrysogenum, grown in aerobic stirred fermenters,
which gives 55-fold higher penicillin yields than the original
static cultures.
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
Table 42.3
995
Property or Product
Transferred
Microorganism U sed
Combinatorial Process
Ethanol production
1,3-Propanediol production
E scherichia coli
E . coli
Cephalosporin precursor
synthesis
Lactic acid production
Xylitol production
Penicillium chrysogenum
Saccharomyces cerev isiae
S. cerev isiae
Creatininaseb
E . coli
Pediocin
S. cerev isiae
T.-Y. Tang; C.-J . Wen; and W.-H. Liu. 2000. Expression of the creatininase gene from Pseud omonas putid a RS65 in E scherichia coli. J . Ind . M icrobiol. B iotechnol. 24:26.
H. Schoeman; M. A. Vivier; M. DuToit; L. M. Y. Dicks; and I. S. Pretorius. 1999. The development of bactericidal yeast strains by expressing the Ped iococcus acid ilactici pediocin gene (pedA) in Saccharomyces
cerev isiae. Y east 15:647656.
Adapted from S. Ostergaard; L. Olsson; and J . Nielson. 2000. Metabolic engineering of Saccharomyces cerev isiae. Microbiol. Mol. Biol. Rev. 64(1):3450.
PrescottHarleyKlein:
Microbiology, Fifth Edition
996
The McGrawHill
Companies, 2002
P las m id
VP # 1
p ro te in
Re s tric tio n
en zym e
Viral RNA
Viral RNA
fo r VP # 1
C le av e d
p las m id
Re v e rs e
tran s c rip tio n
Viral
p ro te in s
Fo o t-an d -m o u th
d is e as e v iru s
Re c o m b in an t
p las m id
T ran s fo rm atio n o f
E. coli
Fo re ig n g e n e
Bac te rial
c h ro m o s o m e
VP # 1
p ro te in
C lo n e o f
re c o m b in an t
b ac te ria
VP # 1 p ro te in fro m re c o m b in an t b ac te ria
fo r u s e in v ac c in e p ro d u c tio n
Figure 42.2 R ecombinant V accine Production. Genes coding for desired products can be expressed in
different organisms. By the use of recombinant DNA techniques, a foot-and-mouth disease vaccine is produced
through cloning the vaccine genes into Escherichia coli.
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
997
Table 42.4 Examples of Recombinant DNA Systems Used to Modify Gene Expression
Product
Microorganism
Change
Actinorhodin
Cellulase
Recombinant protein albumin
Heterologous protein
Enhanced growth ratea
Amino acidsb
Streptomyces coelicolor
Clostridium genes in Bacillus
Saccharomyces cerevisiae
Saccharomyces cerevisiae
A spergillus nidulans
Corynebacterium
a,b
S. Ostergaard; L. Olsson; and J. Nielson. 2000. Metabolic engineering of Saccharomyces cerevisiae. Microbiol. Mol. Biol. R ev. 64(1):3450. Table 1, p. 35
S
E1
E3
E2
P1
P2
P3
E4
E5
E6
E7
P1,2
P1,3
P1,2
P2,3
E10
E11
E10
E12
E8
E9
P1,3
P2,3
E11
E12
FP
1 ,2 ,3
PrescottHarleyKlein:
Microbiology, Fifth Edition
998
The McGrawHill
Companies, 2002
DEB
(a)
HO
HO
HO
HO
HO
O
3
HO
HO
HO
HO
HO
HO
HO
HO
HO
1
S
O
OH
S
O
HO
S
O
S
O
HO
O
M odule 1
M odule 2
M odule 3
M odule 4
M odule 6
M odule 5
M o d ifie d Str u c tu re s
O
(b)
OH
HO
M odule 1
M odule 2
M odule 3
M odule 4
X
Block ed
enzyme
M odule 6
M odule 5
OH
O
O
(c)
O
M odule 1
M odule 2
M odule 3
M odule 4
M odule 6
M odule 5
X
Block ed
enzyme
HO
OH
O
O
Figure 42.4 Metabolic Engineering to Create Modified Antibiotics. (a) Model for six elongation cycles
(modules) in the normal synthesis of 6-deoxyerythonilide B (DEB), a precursor to the important antibiotic
erythromycin. (b) Changes in structure that occur when the enoyl reductase enzyme of module 4 is blocked.
(c) Changes in structure that occur when the keto reductase enzyme of module 5 is blocked. These changed structures
(the highlighted areas) may lead to the synthesis of modified antibiotics with improved properties.
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
999
G lucose
Glucose 6-phosphate
Fructose 6-phosphate
Fructose 1, 6-bisphosphate
Dihydrox yacetone
phosphate
G ly c era ldeh y de
3 - ph osph a te
G ly c oly sis
Methylglyox al
synthase
Methylglyox al
Aldose reductase *
or Glycerol dehydrogenase
Glycerol-3-phosphate
[Hydrox yacetone]
Glycerol
Glycerol dehydratase
1,2-Propanediol
* From rat lens
From E. coli, overexpressed
F rom K. pneumoniae
3-Hydrox ypropionaldehyde
1,3-Propanediolox idoreductase
1,3-Propanediol
D N A C h a n ges M ed ia ted
D eletions and fusions b y nonhom olog ous recom b ination, som etim es at short rep eats
Insertions, ex cisions/deletions, inv ersions b y concerted or successiv e cleav ag e-lig ation reactions at
short seq uence rep eats; tolerates m ism atches
Insertions, transp ositions, rep licon fusions, adjacent deletions/ex cisions, adjacent inv ersions b y lig ation
of 3 O H transp oson ends of 5 P O 4 g roup s from stag g ered cuts at nonhom olog ous targ et sites
U p tak e of sing le strand indep endent of seq uence, or of doub le-stranded D N A carry ing sp ecies
identifier seq uence
A dap ted from J . A . S hap iro. 1 9 9 9 . N atural g enetic eng ineering , adap tiv e m utation, and b acterial ev olution. In m icr ob ia l e colog y of in fe ctiou s d is e a s e , E. R osenb erg , editor, 2 5 9 7 5 . W ashing ton, D .C .: A m erican S ociety
for M icrob iolog y . D eriv ed from T ab le 2 , p p . 2 6 3 6 4.
Preservation of Microorganisms
Once a microorganism or virus has been selected or created to
serve a specific purpose, it must be preserved in its original form
for further use and study. Periodic transfers of cultures have been
used in the past, although this can lead to mutations and pheno-
typic changes in microorganisms. To avoid these problems, a variety of culture preservation techniques may be used to maintain
desired culture characteristics (table 42.6 ). L yophiliz ation, or
freeze-drying, and storage in liquid nitrogen are frequently employed with microorganisms. Although lyophilization and liquid
1000
X I. F ood a n d In d u stria l
M icrob iolog y
Table 42.6
Methods Used to Preserve Cultures of Interest for Industrial Microbiology and Biotechnology
Method
Comments
Periodic transfer
V ariables of periodic transfer to new media include transfer frequency, medium used, and holding
temperature; this can lead to increased mutation rates and production of variants
A stock culture is grown on a slant and covered with sterilized mineral oil; the slant can be stored at
refrigerator temperature
Washed cultures are stored under refrigeration; these cultures can be viable for 3 to 5 months or longer
Not reliable; can result in damage to microbial structures; with some microorganisms, however, this can
be a useful means of culture maintenance
Cultures are dried on sterile soil (soil stocks), on sterile filter paper disks, or in gelatin drops; these can be
stored in a desiccator at refrigeration temperature, or frozen to improve viability
Water is removed by sublimation, in the presence of a cryoprotective agent; sealing in an ampule can lead
to long-term viability, with 30 years having been reported
Liquid nitrogen at 196 C is used, and cultures of fastidious microorganisms have been preserved for
more than 15 years
nitrogen storage are complicated and require expensive equipment, they do allow microbial cultures to be stored for years without loss of viability or an accumulation of mutations.
1. What types of recombinant DNA techniques are being used to
modify gene expression in microorganisms?
2. Define metabolic control engineering, metabolic pathway
engineering, forced evolution, and adaptive mutations.
3. Why might natural genetic engineering be useful in modern
microbial biotechnology?
4. What approaches can be used for the preservation of
microorganisms?
Table 42.7
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
1001
R aw Material
Source
R aw Material
Molasses
Whey
Grains
Agricultural wastes (corncobs)
Vitamins
Nitrogen
Corn-steep liquor
Soybean meal
Stick liquor (slaughterhouse products)
Ammonia and ammonium salts
Nitrates
Distillers solubles
Antifoam agents
(a)
(b)
PrescottHarleyKlein:
Microbiology, Fifth Edition
1002
The McGrawHill
Companies, 2002
Motor
pH prob e
C u ltu re or
n u trien t addition
S ample
lin e
V alve
Impellers
T emperatu re
sen sor an d
con trol u n it
(a)
C oolin g
jack et
B iosen sor
u n it
C oolin g
w ater in
V alve
products, pH, input and exhaust gas composition, and other parameters. Such information is needed for precise process and product control. Environmental conditions can be changed or held constant over
time, depending on the goals for the particular process.
Frequently a critical component in the medium, often the carbon source, is added continuously continuous feed so that
the microorganism will not have excess substrate available at any
given time. An excess of substrate can cause undesirable metabolic waste products to accumulate. This is particularly important
with glucose and other carbohydrates. If excess glucose is present at the beginning of a fermentation, it can be catabolized to
yield ethanol, which is lost as a volatile product and reduces the
final yield. This can occur even under aerobic conditions.
Besides the traditional stirred aerobic or anaerobic fermenter, other approaches can be used to grow microorganisms.
These alternatives, illustrated in figure 42.8, include lift-tube fermenters (figure 42.8a), which eliminate the need for stirrers that
can be fouled by filamentous fungi. Also available is solid-state
fermentation (figure 42.8b), in which the substrate is not diluted
in water. In various types of fixed- (figure 42.8c) and fluidizedbed reactors (figure 42.8d), the microorganisms are associated
with inert surfaces as biofilms (see pp. 6 2 0 2 2 ), and medium
flows past the fixed or suspended particles.
A ir in
V alve
H arvest
lin e
A ir filter
(b )
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
1003
Flow in
(c ) F ix ed -bed reac to r
Fixed
support
material
Microorganisms on surfaces
of support material;
flow can be up or down
Flow out
(d ) F luid iz ed -bed reac to r
Flow out
Microorganisms on surfaces
of particles suspended
in liq uid or gas stream
upward flow
Suspended
support particles
Flow in
Membrane
Culture
Medium
or buffer
Medium in
(f) C o ntinuo us c ulture unit (C h emo s tat)
Medium in and excess
medium to waste with
wasted cells
Medium and
cells out
PrescottHarleyKlein:
Microbiology, Fifth Edition
1004
The McGrawHill
Companies, 2002
42.3
Growth
Primary
metabolite
formation
Antibiotics
Growth
Secondary
metabolite
formation
Many antibiotics are produced by microorganisms, predominantly by actinomycetes in the genus Streptomyces and by filamentous fungi (see table 3 5.2). In this chapter, the synthesis of
several of the most important antibiotics will be discussed to illustrate the critical role of medium formulation and environmental control in the production of these important compounds. Antibiotics in medicine (chapter 35)
Time
Penicillin
Penicillin, produced by P enicillium ch rysogenum, is an excellent
example of a fermentation for which careful adjustment of the
medium composition is used to achieve maximum yields. Rapid
production of cells, which can occur when high levels of glucose
are used as a carbon source, does not lead to maximum antibiotic
Table 42.9 Major Microbial Products and Processes of Interest in Industrial Microbiology and Biotechnology
Substances
Microorganisms
Industrial Products
Ethanol (from glucose)
Ethanol (from lactose)
Acetone and butanol
2,3-butanediol
Enzymes
Agricultural Products
Gibberellins
Food Additives
Amino acids (e.g., lysine)
Organic acids (citric acid)
Nucleotides
Vitamins
Polysaccharides
C
A
C
A
X
Medical Products
Antibiotics
Alkaloids
Steroid transformations
Insulin, human growth hormone, somatostatin, interferons
Biofuels
Hydrogen
Methane
Ethanol
orynebacterium glutamicum
spergillus niger
orynebacterium glutamicum
sh bya, Eremoth ecium, B lak eslea
anth omonas
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
100
Glucose
feeding
1.45 g/liter-hour
N itrogen
feeding
90
1.31
1.15
18 mg/liter-hour
Streptomycin
80
Biomass (g/liter), carbohydrate, ammonia,
p enicillin (g/liter x 1 0 )
1005
Streptomycin is a secondary metabolite produced by Streptomyces griseus, for which changes in environmental conditions
and substrate availability also influence final product accumulation. In this fermentation a soybean-based medium is used with
glucose as a carbon source. The nitrogen source is thus in a combined form (soybean meal), which limits growth. After growth
the antibiotic levels in the culture begin to increase (figure 42.11)
under conditions of controlled nitrogen limitation.
The field of antibiotic development continues to expand. At
present, 6,000 antibiotics have been described, with 4,000 of
these derived from actinomycetes. About 300 new antibiotics are
being discovered per year.
L actose
70
60
Penicillin
50
40
Biomass
30
20
Amino Acids
10
Amino acids such as lysine and glutamic acid are used in the food
industry as nutritional supplements in bread products and as flavorenhancing compounds such as monosodium glutamate (MSG).
Amino acid production is typically carried out by means of
regulatory mutants, which have a reduced ability to limit synthesis of an end product. The normal microorganism avoids overproduction of biochemical intermediates by the careful regulation of
cellular metabolism. Production of glutamic acid and several other
amino acids in large quantities is now carried out using mutants of
0
0
20
40
60
80
100
120
Fermentation time (hours)
140
400
300
200
100
Streptomycin
concentration
16
14
Mycelial
biomass
12
9.0
Glucose
concentration
10
pH Value
8.0
8
6
7.0
4
2
0
4
5
6
7
8
F ermentation time (days)
10
11
6.0
p H v alue
Ammonia
PrescottHarleyKlein:
Microbiology, Fifth Edition
1006
The McGrawHill
Companies, 2002
Glucose
Glucose
Glucose 6-phosphate
Glucose 6-phosphate
Triose phosphate
Triose phosphate
CO2
CO2
Acetyl-CoA
C3
CO2
CO2
CO2
CO2
Acetyl-CoA
C3
CO2
CO2
Oxaloacetate
CO2
Citrate
Oxaloacetate
CO2
Acetyl-CoA
Malate
Malate
synthetase
Malate
CHO
COO
Glyoxylate
cis-Aconitate
Malate
synthetase
CHO
COO
Glyoxylate
cis-Aconitate
Fumarate
Fumarate
Isocitrate Iyase
Isocitrate
Isocitrate Iyase
Isocitrate
Succinate
Succinate
Oxalosuccinate
Succinyl-CoA
K etoglutarate
K etoglutarate
CO2
Glutamate
Oxalosuccinate
Succinyl-CoA
NH4+
(a)
Citrate
Acetyl-CoA
CO2
NH4+
(b)
Glutamate
Figure 42.12 Glutamic Acid Production. The sequence of biosynthetic reactions leading from glucose to the
accumulation of glutamate by Corynebacterium glutamicum. Major carbon flows are noted by bold arrows.
(a) Growth with use of the glyoxylate bypass to provide critical intermediates in the TCA cycle. (b) After growth
is completed, most of the substrate carbon is processed to glutamate (note shifted bold arrows). The dashed lines
indicate reactions that are being used to a lesser extent.
Corynebacterium glutamicum that lack, or have only a limited ability to process, the TCA cycle intermediate -ketoglutarate (see appendix II) to succinyl-CoA as shown in figure 42.12. A controlled
low biotin level and the addition of fatty acid derivatives results in
increased membrane permeability and excretion of high concentrations of glutamic acid. The impaired bacteria use the glyoxylate
pathway (see section 10.6) to meet their needs for essential biochemical intermediates, especially during the growth phase. After
growth becomes limited because of changed nutrient availability,
an almost complete molar conversion (or 81.7% weight conversion) of isocitrate to glutamate occurs.
Lysine, an essential amino acid used to supplement cereals
and breads, was originally produced in a two-step microbial
process. This has been replaced by a single-step fermentation in
which the bacterium Corynebacterium glutamicum, blocked in
the synthesis of homoserine, accumulates lysine. Over 44 g/liter
can be produced in a 3 day fermentation.
Although not used extensively in the United States, microorganisms with related regulatory mutations have been employed to
produce a series of 5 purine nucleotides that serve as flavor enhancers for soups and meat products.
O rganic Acids
Organic acid production by microorganisms is important in industrial microbiology and illustrates the effects of trace metal levels and
balances on organic acid synthesis and excretion. Citric, acetic, lactic, fumaric, and gluconic acids are major products (table 42.10).
Until microbial processes were developed, the major source of citric
acid was citrus fruit from Italy. Today most citric acid is produced by
microorganisms; 70% is used in the food and beverage industry, 20%
in pharmaceuticals, and the balance in other industrial applications.
The essence of citric acid fermentation involves limiting the
amounts of trace metals such as manganese and iron to stop As-
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
Companies, 2002
1007
Microorganism Used
Representative Uses
Fermentation Conditions
Acetic acid
Citric acid
Fumaric acid
Gluconic acid
Itaconic acid
K ojic acid
Lactic acid
Homofermentative L actobacillus
delbrueckii
Biopolymers
Biopolymers are microbially produced polymers used to modify the
flow characteristics of liquids and to serve as gelling agents. These
are employed in many areas of the pharmaceutical and food industries. The advantage of using microbial biopolymers is that production is independent of climate, political events that can limit raw material supplies, and the depletion of natural resources. Production
facilities also can be located near sources of inexpensive substrates
(e.g., near agricultural areas). Bacterial exopolysaccharides (p. 61)
At least 75% of all polysaccharides are used as stabilizers,
for the dispersion of particulates, as film-forming agents, or to
promote water retention in various products. Polysaccharides
help maintain the texture of many frozen foods, such as ice cream,
that are subject to drastic temperature changes. These polysaccharides must maintain their properties under the pH conditions
in the particular food and be compatible with other polysaccharides. They should not lose their physical characteristics if heated.
Biopolymers include (1) dextrans, which are used as blood
expanders and absorbents; (2) Erw inia polysaccharides that are in
PrescottHarleyKlein:
Microbiology, Fifth Edition
1008
The McGrawHill
Companies, 2002
Source
Specific Product
Process/Organism Affected
Polyethers
Streptomyces cinnamonensis
S. lasaliensis
S. albus
S. avermitilis
Aspergillus terreus
Penicillium citrinum
actinomycetea
S. clavaligerus
Actinoplanes sp.
Monensin
Lasalocid
Salinomycin
Clavulanic acid
Acarbose
S. hygroscopicus
Tolypocladium inflatum
S. tsukabaensis
S. hygroscopicus
Gibberella zeae
Claviceps purpurea
S. peuceticus subsp. caesius
S. peuceticus
S. caespitosus
S. verticillus
Bialaphos
Cyclosporin A
FK-506
Rapamycin
Z earalenone
Ergot alkaloids
Doxorubicin
Daunorubicin
Mitomycin
Bleomycin
Avermectins
Statins
Enzyme inhibitors
Bioherbicide
Immunosuppressants
Anabolic agents
Uterocontractants
Antitumor agents
Lovastatin
Pravastatin
Penicillinase inhibitor
Intestinal glucosidase inhibitor (decreases hyperglycemia and
triglyceride synthesis)
Organ transplants
Organ transplants
Organ transplants
Farm animal medication
Induction of labor
Cancer treatment
Cancer treatment
Cancer treatment
Cancer treatment
Based on: A. L. Demain. 2000. Microbial biotechnology. Tibtech 18:2631; A. L. Demain. 2000. Pharmaceutically active secondary metabolites of microorganisms. App. Microbiol. Biotechnol. 52:455463; G. Lancini;
A. L. Demain. 1999. Secondary metabolism in bacteria: Antibiotic pathways regulation, and function. In Biology of the prokaryotes, J. W. Lengeler, G. Drews, and H. G. Schlegel, editors, 62751. New Y ork: Thieme.
HO
HO
OH
HO
CH 2OH
O
OH
2
O
CH
HO
CH
2 OH
O
O O
H
H
O
H2 O
CH
OH
OH
O
CH 2OH
O
CH2 OH
O
HO
2O
CH
O
OH
OH
HO
HO
CH
2O
H
CH O
2 H
CH 2OH
O
HO
HO
OH
2O
HO
OH
HO
OH
CH
HO
CH2OH
O
HO
-Cy c lo d e x trin
HO
OH
HO
OH
OH
HO
HO
HO
CH O
2 H
HO
2O
CH
OH
CH 2
O
-Cy c lo d e x trin
2O
OH
HO
OH
CH
2O
HO
2O
CH 2OH
O
OH
CH
OH
OH
OH
OH
CH 2
O
OH
OH
CH 2
O
-Cy c lo d e x trin
Figure 42.13 Cyclodex trins. The basic structures of cyclodextrins produced by Thermoanaerobacter are illustrated
here. These unique oligopolysaccharides have many applications in medicine and industry.
of xanthan gum, produced by Xanthomonas campestris, represents a large potential market for this microbial product.
The cyclodextrins have a unique structure, as shown in figure 42.13. They are cyclic oligosaccharides whose sugars are
joined by -1,4 linkages. Cyclodextrins can be used for a wide
variety of purposes because these cyclical molecules bind with
PrescottHarleyKlein:
Microbiology, Fifth Edition
The McGrawHill
C o m p a n ie s , 2 0 0 2
substances and modify their physical properties. For example, cyclodextrins w ill increase the solubility of pharmaceuticals, reduce
their bitterness, and mask chemical odors. C yclodextrins also can
be used as selectiv e adsorbents to remov e cholesterol from eg g s
and butter or protect spices from oxidation.
Biosurfactants
M any surfactants that hav e been used for commercial purposes
are products of synthetic chemistry. A t the present time there is
an increasing interest in the use of biosurfactants. T hese are especially important for env ironmental applications w here
biodeg radability is a major req uirement. B iosurfactants are used
for emulsification, increasing deterg ency, w etting and phase dispersion, as w ell as for solubiliz ation. T hese properties are especially important in bioremediation, oil spill dispersion, and enhanced oil recov ery (E O R ).
T he most w idely used microbially produced biosurfactants
are g lycolipids. T hese compounds hav e distinct hydrophilic and
hydrophobic reg ions, and the final compound structure and characteristics depend on the particular g row th conditions and the carbon source used. G ood yields often are obtained w ith insoluble
substrates. T hese biosurfactants are excellent dispersing ag ents
and hav e been used w ith the Exxon Valdez oil spill.
CH
C
1009
CH
H O
Rhizopus nigricans
O
M a jo r p ro d u c t
source such as g lucose must be supplied under carefully controlled nong row th conditions.
W hen freely suspended v eg etativ e cells or spores are employed,
the microbial biomass usually is used only once. A t the end of the
process, the cells are discarded. C ells often can be used repeatedly after attaching them to ion exchang e resins by ionic interactions or immobiliz ing them in a polymeric matrix. Ionic, cov alent, and physical
entrapment approaches can be used to immobiliz e microbial cells,
spores, and enz ymes. M icroorg anisms also can be immobiliz ed on the
inner w alls of fine tubes. T he solution to be modified is then simply
passed throug h the microorg anism-lined tubing ; this approach is being applied in many industrial and env ironmental processes. T hese include bioconv ersions of steroids, deg radation of phenol, and the production of a w ide rang e of antibiotics, enz ymes, org anic acids, and
metabolic intermediates. O ne application of cells as biocatalysts is the
recov ery of precious metals from dilute-process streams.
1 . D iscuss the major uses for biopolymers and biosurfactants.
2 . W hat are cyclodextrins and w hy are they important additiv es?
3 . W hat are bioconv ersions or biotransformations? D escribe the
chang es in molecules that result from these processes.
4 2 .4